TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Invex Therapeutics Ltd. ( (AU:IXC) ) just unveiled an update.
Invex Therapeutics Ltd has requested a trading halt on its securities pending a significant announcement regarding a material acquisition and a response to an ASX price query. This trading halt is expected to last until the announcement is released or normal trading resumes on 25 September 2025, potentially impacting the company’s market positioning and stakeholder interests.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd is a company operating in the biotechnology industry, focusing on developing treatments for neurological conditions. The company is listed on the Australian Securities Exchange (ASX) under the ticker IXC.
Average Trading Volume: 51,691
Technical Sentiment Signal: Buy
Current Market Cap: A$7.89M
Learn more about IXC stock on TipRanks’ Stock Analysis page.